|国家科技期刊平台
首页|期刊导航|临床口腔医学杂志|TP53突变影响口腔鳞癌PD-1表达相关性的临床分析

TP53突变影响口腔鳞癌PD-1表达相关性的临床分析OACSTPCD

Clinical analysis of oral squamous cell carcinoma and mutant TP53 and PD-1 expression and correlation

中文摘要英文摘要

目的:探讨在口腔鳞癌中TP53突变对肿瘤微环境中程序性死亡受体-1(programmed death receptor-1,PD-1)表达的影响.方法:以口腔鳞癌患者为研究对象,分别收集癌灶、癌旁及外周血的标本,同时整理其临床资料.通过全外显子测序技术和病理学检测的方法检测患者TP53基因突变及PD-1 蛋白表达.结果:共纳入 12 例口腔鳞癌患者,TP53基因突变者 7 例(58.3%),PD-1蛋白阳性表达者 7 例(58.3%).PD-1 蛋白表达与患者年龄、性别、肿瘤大小及颈淋巴结转移未见统计学相关,TP53基因变异与患者年龄、性别、肿瘤大小及颈淋巴结转移亦未见相关性.TP53基因突变与PD-1蛋白表达存在相关性.结论:口腔鳞癌患者中TP53基因突变可能和肿瘤微环境中PD-1 的表达存在相关性,TP53基因突变有可能作为口腔鳞癌免疫治疗有效标记物.

Objective:To investigate the effect of TP53 mutation on programmed death receptor-1(PD-1)expression in the tumour microenvironment in oral squamous cell carcinoma.Methods:Oral squamous cell carcinoma patients were taken as research subjects,and specimens of cancer foci,paracancerous and peripheral blood were collected respectively,while their clinical data were collated.The TP53 gene mutation status and PD-1 protein expression of the patients were detected by the whole-exon sequencing method and pathological detection.Results:A total of 12 oral squamous cell carcinoma patients were enrolled,among whom 7(58.3%)had TP53 gene mutation and 7(58.3%)had positive PD-1 protein expression.There was no statistically significant correlation between the expression of PD-1 protein and the age,gender,tumour size and cervical lymph node metastasis of the patients,nor was there any correlation between the TP53 gene mutation and the age,gender,tumour size and cervical lymph node metastasis of the patients.There was also no correlation between TP53 gene variants and patients'age,gender,tumour size and cervical lymph node metastasis.Conclusion:TP53 gene mutations in oral squamous cell carcinoma patients may be correlated with the expression of PD-1 in the tumour microenvironment,and TP53 gene muta-tions have the potential to be used as a marker for immunotherapy heat in oral squamous cell carcinoma.

李文强;秦旭;胡传宇;黄春明;黄平;周磊磊;李殿奇

华中科技大学同济医学院附属同济医院口腔医学中心 湖北 武汉 430030||华中科技大学同济医学院口腔医学院 湖北 武汉 430030

临床医学

口腔鳞状细胞癌程序性死亡受体-1(PD-1)TP53免疫治疗

Oral squamous cell carcinomaProgrammed death receptor-1(PD-1)TP53Immunotherapy

《临床口腔医学杂志》 2024 (008)

469-471 / 3

湖北省自然科学基金项目(2023AFB765)

10.3969/j.issn.1003-1634.2024.08.006

评论